Perceptive Advisors Trimmed Its Position in Nxstage Medical (NXTM) as Market Valuation Declined; Perrigo Co Plc Shs (PRGO) Holder Mivtachim The Workers Social Insurance Fund LTD Decreased Its Stake by $4.54 Million

January 14, 2018 - By reb123z

Mivtachim The Workers Social Insurance Fund Ltd decreased its stake in Perrigo Co Plc Shs (PRGO) by 27.74% based on its latest 2017Q3 regulatory filing with the SEC. Mivtachim The Workers Social Insurance Fund Ltd sold 54,000 shares as the company’s stock declined 16.20% while stock markets rallied. The institutional investor held 140,656 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $11.91M, down from 194,656 at the end of the previous reported quarter. Mivtachim The Workers Social Insurance Fund Ltd who had been investing in Perrigo Co Plc Shs for a number of months, seems to be less bullish one the $12.93 billion market cap company. The stock decreased 0.21% or $0.19 during the last trading session, reaching $91.8. About 559,679 shares traded. Perrigo Company plc (NYSE:PRGO) has declined 23.00% since January 14, 2017 and is downtrending. It has underperformed by 39.70% the S&P500.

Joseph Edelman decreased its stake in Nxstage Medical Inc (NXTM) by 18.71% based on its latest 2017Q3 regulatory filing with the SEC. Perceptive Advisors Llc sold 291,000 shares as the company’s stock declined 27.12% while stock markets rallied. The hedge fund run by Joseph Edelman held 1.26M shares of the health care company at the end of 2017Q3, valued at $34.90M, down from 1.56 million at the end of the previous reported quarter. Perceptive Advisors Llc who had been investing in Nxstage Medical Inc for a number of months, seems to be less bullish one the $1.64B market cap company. The stock increased 0.41% or $0.1 during the last trading session, reaching $24.77. About 249,677 shares traded. Nxstage Medical, Inc. (NASDAQ:NXTM) has risen 21.18% since January 14, 2017 and is uptrending. It has outperformed by 4.48% the S&P500.

Perceptive Advisors Llc, which manages about $2.09B and $2.62B US Long portfolio, upped its stake in Global Blood Therapeutics In by 330,139 shares to 4.26 million shares, valued at $132.40M in 2017Q3, according to the filing. It also increased its holding in Tesaro Inc (NASDAQ:TSRO) by 29,100 shares in the quarter, for a total of 388,651 shares, and has risen its stake in Anaptysbio Inc.

Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.23, from 1.14 in 2017Q2. It worsened, as 50 investors sold NXTM shares while 41 reduced holdings. 51 funds opened positions while 32 raised stakes. 51.56 million shares or 12.24% less from 58.75 million shares in 2017Q2 were reported. Legal & General Grp Inc Public Limited Com invested in 32,192 shares or 0% of the stock. Morgan Stanley has invested 0% in Nxstage Medical, Inc. (NASDAQ:NXTM). Gilder Gagnon Howe And Limited Liability holds 1.58 million shares or 0.61% of its portfolio. Fmr Ltd Liability has invested 0% in Nxstage Medical, Inc. (NASDAQ:NXTM). Longfellow Investment Com Ltd Liability Co holds 13,500 shares or 0.1% of its portfolio. Tiaa Cref Invest Mngmt Limited Company holds 250,655 shares or 0% of its portfolio. Geode Cap has 0.01% invested in Nxstage Medical, Inc. (NASDAQ:NXTM) for 707,075 shares. Royal Comml Bank Of Canada reported 9,419 shares. 4.28 million are owned by Blackrock. Moreover, Schwab Charles Invest Mgmt Inc has 0.01% invested in Nxstage Medical, Inc. (NASDAQ:NXTM). Omni Prtn Llp invested in 337,893 shares. Grp Incorporated has invested 0% in Nxstage Medical, Inc. (NASDAQ:NXTM). Vertex One Asset Mngmt owns 105,500 shares for 0.47% of their portfolio. Ameritas Prtn has invested 0.01% in Nxstage Medical, Inc. (NASDAQ:NXTM). Moreover, Tiverton Asset Mgmt Ltd Limited Liability Company has 0.15% invested in Nxstage Medical, Inc. (NASDAQ:NXTM) for 98,404 shares.

Since August 3, 2017, it had 0 buys, and 11 insider sales for $1.60 million activity. The insider Turk Joseph E Jr sold 1,000 shares worth $29,260. $125,646 worth of Nxstage Medical, Inc. (NASDAQ:NXTM) shares were sold by TOWSE MATTHEW W.

Among 9 analysts covering NxStage Medical (NASDAQ:NXTM), 2 have Buy rating, 1 Sell and 6 Hold. Therefore 22% are positive. NxStage Medical had 18 analyst reports since November 4, 2015 according to SRatingsIntel. BTIG Research downgraded the stock to “Neutral” rating in Friday, August 11 report. Piper Jaffray reinitiated Nxstage Medical, Inc. (NASDAQ:NXTM) rating on Thursday, March 31. Piper Jaffray has “Overweight” rating and $18.50 target. As per Tuesday, October 10, the company rating was maintained by Jefferies. The rating was initiated by Sterne Agee CRT with “Buy” on Friday, December 11. The stock of Nxstage Medical, Inc. (NASDAQ:NXTM) has “Outperform” rating given on Tuesday, June 28 by Northland Capital. As per Monday, August 7, the company rating was downgraded by Canaccord Genuity. The stock of Nxstage Medical, Inc. (NASDAQ:NXTM) earned “Hold” rating by Canaccord Genuity on Monday, October 16. Leerink Swann downgraded the shares of NXTM in report on Tuesday, August 22 to “Market Perform” rating. The stock has “Buy” rating by Canaccord Genuity on Tuesday, August 2. The rating was downgraded by Jefferies to “Hold” on Tuesday, August 8.

Investors sentiment decreased to 0.79 in Q3 2017. Its down 0.09, from 0.88 in 2017Q2. It dived, as 42 investors sold PRGO shares while 143 reduced holdings. 57 funds opened positions while 89 raised stakes. 112.10 million shares or 2.05% less from 114.45 million shares in 2017Q2 were reported. Goldman Sachs Group Incorporated holds 0.05% of its portfolio in Perrigo Company plc (NYSE:PRGO) for 2.22M shares. State Teachers Retirement invested in 0.05% or 230,475 shares. Finemark National Bank & Trust And Tru holds 0.02% of its portfolio in Perrigo Company plc (NYSE:PRGO) for 3,154 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh invested in 0.23% or 67,831 shares. Prudential Financial holds 0.03% of its portfolio in Perrigo Company plc (NYSE:PRGO) for 183,006 shares. Pinebridge Invests Limited Partnership invested in 0% or 523 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.02% or 24,939 shares. Franklin Resource holds 0.34% or 8.09 million shares. Moreover, Davenport Limited Liability Corporation has 0% invested in Perrigo Company plc (NYSE:PRGO) for 2,719 shares. Spirit Of America Mgmt reported 1,300 shares stake. Nationwide Fund Advsrs owns 51,540 shares or 0.02% of their US portfolio. Moreover, Sivik Global Health Limited Liability has 0.72% invested in Perrigo Company plc (NYSE:PRGO) for 25,000 shares. Royal National Bank Of Canada owns 8,058 shares or 0% of their US portfolio. Ftb Advisors, Tennessee-based fund reported 40,703 shares. Parametric Portfolio Limited Liability Corporation has 0.02% invested in Perrigo Company plc (NYSE:PRGO).

Analysts await Perrigo Company plc (NYSE:PRGO) to report earnings on May, 28. They expect $1.23 earnings per share, down 0.81% or $0.01 from last year’s $1.24 per share. PRGO’s profit will be $173.23 million for 18.66 P/E if the $1.23 EPS becomes a reality. After $1.39 actual earnings per share reported by Perrigo Company plc for the previous quarter, Wall Street now forecasts -11.51% negative EPS growth.

Among 19 analysts covering Perrigo Company Plc (NYSE:PRGO), 8 have Buy rating, 0 Sell and 11 Hold. Therefore 42% are positive. Perrigo Company Plc had 71 analyst reports since October 23, 2015 according to SRatingsIntel. The stock of Perrigo Company plc (NYSE:PRGO) earned “Equal-Weight” rating by Morgan Stanley on Tuesday, April 26. The company was maintained on Tuesday, February 28 by Canaccord Genuity. The stock has “Market Perform” rating by Wells Fargo on Monday, April 25. The firm earned “Buy” rating on Thursday, December 10 by Argus Research. On Monday, January 23 the stock rating was maintained by Jefferies with “Hold”. The company was maintained on Wednesday, May 31 by Jefferies. The firm has “Buy” rating given on Friday, July 22 by Deutsche Bank. The firm has “Buy” rating given on Wednesday, September 6 by Oppenheimer. The rating was maintained by B. Riley & Co with “Neutral” on Friday, March 3. Deutsche Bank maintained the stock with “Buy” rating in Thursday, August 11 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>